Skip to main content

Table 1 Clinical characteristics of the study cohort at baseline

From: A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report

Variable

  

Number

N

52

Practice

A

28 (54)

 

B

24 (46)

Age

Years

57.5 (47–64)

Gender

Male

25 (48)

 

Female

27 (52)

Ethnicity

New Zealand European

5 (10)

 

Cook Island Maori/Samoan

10 (19)

 

New Zealand Maori

37 (71)

Appropriate secondary specialist care

 

15 (29)

Total chronic medical illness burden

CIRS Score

6.92 (2.27)

2 or more diagnoses (CIRS domains)

%

33

3 or more diagnoses (CIRS domains)

%

3

4 or more diagnoses (CIRS domains)

%

0

Albumin to creatinine ratio

mg/mmol

34.9 (14.2-150.9)

5-year absolute cardiovascular risk

%

20 (15–27)

Estimated GFR

mL/min/1.73 m2

63 (48–77)

Systolic BP

mmHg

150 (144.5-160)

Diastolic BP

mmHg

90 (80–110)

Serum total cholesterol

mmol/L

5.25 (4.1-6)

Glycosylated haemoglobin

%

8.8 (7.7-10.7)

Body mass index

kg/m2

37 (32.5-43.5)

Active smoking

 

18 (35)

Self-management

Score

 

Overall score (scale 0 to 104)

 

82 (72–91)

Knowledge of medications (scale 0 to 8)

 

6 (5–8)

Knowledge of condition (scale 0 to 8)

 

6 (4–7)

Medication adherence (scale 0 to 8)

 

8 (5–8)

Healthy lifestyle (scale 0 to 8)

 

6 (4–8)

Prescribed aspirin

%

31 (60)

Prescribed ACEi / ARBs

%

45 (87)

Prescribed HMG-CoA reductase inhibitors

%

32 (62)

Number of prescribed anti-hypertensives

n

2 (1–3)

  1. All data are presented as n (%) or median (IQR).